2012
DOI: 10.1016/j.jacc.2012.11.002
|View full text |Cite
|
Sign up to set email alerts
|

The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues

Abstract: The environment in which the field of cardiology finds itself has been rapidly changing. This supplement, an expansion of a report created for the Board of Trustees, is intended to provide a timely snapshot of the socio-economic, political, and scientific aspects of this environment as it applies to practice both in the United States and internationally. This publication should assist healthcare professionals looking for the most recent statistics on cardiovascular disease and the risk factors that contribute … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
404
4
26

Year Published

2013
2013
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 683 publications
(460 citation statements)
references
References 76 publications
2
404
4
26
Order By: Relevance
“…83 Thus, overall, CR is available in 83 out of the 214 (38.8%) countries worldwide. CR services are available in only 23% of the LMICs, where 80% of CVD deaths occur 84 underlining the insufficient supply of CR in countries with the greatest cardiovascular burden. There is an inverse relationship between the availability of CR and the number of patients indicated for CR therapy.…”
Section: Cr Availability In Low-income Countriesmentioning
confidence: 99%
“…83 Thus, overall, CR is available in 83 out of the 214 (38.8%) countries worldwide. CR services are available in only 23% of the LMICs, where 80% of CVD deaths occur 84 underlining the insufficient supply of CR in countries with the greatest cardiovascular burden. There is an inverse relationship between the availability of CR and the number of patients indicated for CR therapy.…”
Section: Cr Availability In Low-income Countriesmentioning
confidence: 99%
“…Cardiovascular disease is the leading cause of mortality in developed countries and costs the global economy approximately US$3.7 trillion per annum [1]. As such, interventions that can lower cardiovascular disease morbidity will be of epidemiological and economic importance.…”
Section: Introductionmentioning
confidence: 99%
“…Cardiovascular disease (CVD) accounts for nearly half of the noncommunicable diseases leading to the global cause of mortality (1) . With increased pace of technological advancements, minimally invasive image‐guided cardiovascular interventions are gaining importance across various health‐care centers for the diagnosis of CVDs.…”
Section: Introductionmentioning
confidence: 99%